Full text is available at the source.
Abstract
A single moderate dose of psilocybin (0.215 mg kg-1) resulted in significant reductions in depressive symptoms in 37 individuals diagnosed with major depressive disorder.
- Depressive symptoms were assessed using Beck's depression inventory and the Montgomery-Åsberg depression rating scale.
- Two weeks after administration, participants receiving psilocybin showed a significant increase in positive self-concept compared to those receiving placebo.
- Changes in self-concept were significantly correlated with reductions in depressive scores.
- Neuroimaging indicated psilocybin altered caudate activation related to externally oriented attention, differing from placebo effects during self-referential processing.
- Results suggest that alterations in self-referential processing and self-concept may occur alongside improvements in depressive symptoms.
Simplified